FT specific use-results survey Outcome research of patients who enrolled in a NSAS-BC 01 trial or CUBC trial
Not Applicable
Completed
- Conditions
- Breast cancer
- Registration Number
- JPRN-jRCT1080223266
- Lead Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Female
- Target Recruitment
- 967
Inclusion Criteria
Among the patients enrolled in NSAS-BC01 study and CUBC study, those who are surviving or lost to follow up at the 5-year survival analysis are included in the surveillance analysis.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method